Patent Attorney Bao Tran breaks down the essential intellectual property strategies every startup founder and entrepreneur needs to protect their core innovation, brand, and enterprise value.

Did you know that IP-intensive industries generated $11.4 trillion (44% of U.S. private-sector GDP) in 2024? Yet, far too many software and tech startups leave their source code, brand identity, and proprietary algorithms legally exposed. In this episode, we unpack the four core pillars of U.S. intellectual property—Patents, Trademarks, Copyrights, and Trade Secrets—and explain how to layer them to build a defensible, venture-ready company.

• Utility Patents & Provisional Filings: How utility patents give you a 20-year monopoly on functional innovations, how software eligibility works under 35 U.S.C. §101, and how filing a provisional application locks in your priority date for 12 months.
• Trademarks & Brand Identity: The distinction between common-law rights and federal registration on the USPTO Principal Register, along with required renewal filings between years 5–6, 9–10, and every 10 years.
• Software Copyrights: Why copyright automatically attaches upon fixation, why registering within 3 months of publication under 17 U.S.C. §412 is critical for statutory damages, and why copyright covers written code expression rather than underlying algorithms.
• Trade Secrets & NDAs: How to protect backend algorithms, weights, and customer databases under the Defend Trade Secrets Act using reasonable secrecy measures, and why trade secrets do not shield against legal reverse engineering.
• VC Due Diligence & IP Ownership: Why patent rights vest in individual inventors and contractor work remains owned by contractors unless explicit written assignment agreements are signed, plus why first-time patent applicants experience 80% higher sales growth five years after grant.

• 00:00 – Introduction & Welcome to Patent PC with Bao Tran
• 01:30 – The $11.4 Trillion IP Economy: Why Intangibles Matter
• 04:15 – Utility Patents, Software Eligibility (§101), and Provisional Timelines
• 10:45 – Trademarks: Common Law vs. USPTO Federal Registration
• 16:20 – Copyrighting Source Code & The 3-Month §412 Rule
• 21:10 – Trade Secrets, NDAs, and Backend Protection
• 26:00 – Contractor Assignments, Cap Tables, and VC Valuation Impact
• 31:15 – Founder IP Checklist & Key Takeaways

1. Audit Assets: Map source code, brand names, backend models, and processes to the right IP right.
2. File Provisionals Early: Lock in your filing date before public launch or investor pitches.
3. Register Copyrights: Submit software code to the U.S. Copyright Office within 3 months of publication.
4. Contractor IP Assignments: Ensure all employees and contractors sign written IP assignment clauses before seeing proprietary code.

• YouTube Channel: Patent PC
• Host: Bao Tran
• Subscribe: Don't forget to follow the show on Spotify and hit the bell icon for weekly legal insights!

• 
  

Bao describes his path from being a lawyer at Fish & Richardson to going in-house at Align (Invisalign) through its 2000 IPO, then leaving to work with startups and ultimately focusing on helping founders with funding, business strategy, and IP. He discusses CIS Bay/Sisbay, an AgTech microbial product that improves plant yields by helping roots and nutrient absorption, gaining added relevance when fertilizer costs spiked after the Russia-Ukraine war; because the business expanded from California to Mexico, Brazil, Argentina, and Southeast Asia, global brand protection was necessary. Bao explains how patents and trademarks help create exclusivity and investor confidence, especially in AI where copying is faster, and adds trade secrets as another key protection for model training and data. He argues AI should be a co-pilot guided by experts, noting it enables much deeper patent disclosures and stronger long-term continuation strategies, and he frames patents for founders as valuable assets with strong ROI. The episode also highlights Trademarkia’s scale and accessibility, and Bao shares PatentPC’s

contact details (patentpc.com, 669-232-3440).00:00 Meet Bao and Background00:09 From Big Law to Startups01:15 Mic Troubles Quick Reset02:01 Why Startups Are More Fun03:09 Sisbay AgTech Explained04:36 Global Branding and Expansion05:12 IP Moats for Investors06:15 AI Changes IP Strategy07:02 Why Not Rely on AI Alone08:20 AI Streamlines Patent Drafting09:32 Advice for Founder Inventors11:20 What’s Next and AI Enforcement12:30 Trademarkia Overview13:19 Patent PC and Closing14:11 Where to Find Bao

The script advises investors how to evaluate startups that claim patent filings by checking whether applications are provisional or non-provisional, ensuring provisionals contain substantial technical detail, and confirming the company has a docket and someone responsible for converting to a non-provisional within one year. It warns that missing the deadline—especially after sales or public use—can create prior art that destroys patent rights, leaving only the possibility of patenting a later “version two.” It explains why detailed provisionals are valuable (e.g., drug companies use them to effectively extend patent life to 21 years) and emphasizes strong patents for business exclusivity. The discussion then covers how companies protect evolving software through foundational patents kept alive via continuation applications, plus filing new patents around upcoming releases by identifying market-facing features and their technical implementation.00:00 Investor Due Diligence on Startup Patents

03:22 Patents for Iterations05:45 Feature-Driven IP Strategy06:48 Wrap Up and Takeaways

The script explains three patent types—utility (covers how an invention works), design (covers how it looks, e.g., the Coke bottle ridges and Apple’s rounded-rectangle phone design), and plant patents—then notes that for most software/mechanical/electrical inventions the focus is utility and design, with utility filings split into provisional (temporary) and non-provisional (examined) applications. It discusses how identical business names can coexist under common-law trademark rights in different regions, and how federal registration can create nationwide rights with geographic carve-outs for prior local users, citing an Illinois Burger King example. It recounts securing the “Startup Heiman” trademark by disclaiming exclusivity to “startup” alone. It warns against DIY patent filings due to thin disclosure, lack of process knowledge, and strategic claim drafting, and details the ALICE/101 subject-matter test and its uncertainty, including an examiner deeming a sensor-based wearable light-reflection invention “abstract.”

00:00 Patent Types

01:40 Trademark Coexistence

04:04 Startup Hype Man Case

05:28 DIY IP Filing Pitfalls

13:23 ALICE Test Demystified

Tonya Long moderates a panel with Sudhir Kadam, John Cowan, Bao Tran, and co-moderator Shilpa on how startups evolve from easily built AI products into scalable, defensible businesses that investors fund. They argue product-market fit is the beginning of a “crossing the chasm” transformation: shifting from product to business, delivering complete solutions, building repeatable customer acquisition and sales processes, avoiding custom work disguised as product, and hiring talent suited to each stage. Bao emphasizes defensibility through IP and strategy, sharing Invisalign’s patent “moat” example, while John cautions patents can be hard to enforce and stresses execution, distribution, and niche underserved segments. The panel discusses changing early-stage capital sources toward family offices and direct investors focused on clear liquidity paths and suggests broader fundraising approaches like 506(c) solicitation and using AI to attract investors. They close advising founders to deepen customer understanding, balance conviction with pivoting, and iterate rapidly with AI.

00:00 Welcome and Setup

01:24 Meet the Panel

04:29 Three Big Questions

05:17 Scaling Past PMF

08:28 Repeatability Traps

10:49 Hiring for Growth Stages

16:52 Investor Signals and Team Fit

17:14 Building Moats with IP

21:32 AI Era Capital Efficiency

22:03 Service Plus AI TAM

23:20 Human Hybrid Reality

24:30 Series A Market Signals

25:48 Moats And Defensibility

26:49 Patents As Business Tool

29:54 Execution Beats IP

32:11 Niche Strategy Moat

33:14 Investor Liquidity Shift

38:29 Beyond Silicon Valley Capital

42:11 Founder Focus Next Year

44:04 Closing Takeaways Thanks

VISIT US;

www.patentpc.com

The script discusses “vibe coding” and AI coding tools that let founders and lower-skill programmers build MVPs quickly (e.g., a low-fi DocuSign clone in a day), aligning with lean iteration to test traction faster. The upside is major efficiency gains and amplified developer productivity; the downside is AI-generated code is often unoptimized, requiring later professionalization and scaling work. From a patent-law perspective, AI makes cloning software easy, so IP strategy should be front-loaded: document ideas early, file provisional patents during rapid iterations (possibly multiple), then consolidate into a non-provisional once the design stabilizes for a 1.0 release. Legally, code generated solely by AI isn’t protectable, but human-guided work where the creator retains creative control can be; founders should document their control and claim only the truly novel aspects. The script also argues VCs have deprioritized patents due to cost and time, but AI-assisted drafting can reduce both, and stronger IP moats may matter more as copying gets easier.

Timestamps

00:00 Vibe Coding Explained

00:45 Speed Versus Scale

01:44 Patent Early Strategy

03:25 Lean Iteration Workflow

05:24 Authorship And Protection

07:21 Claim the Real Invention

08:34 VCs And The IP Moat

10:19 Why Patents Matter Now

The script explains misconceptions and pitfalls in protecting life sciences R&D across long development cycles, emphasizing managing scientific, IP, and commercialization risks from basic research through drug discovery, preclinical work, clinical trials, and post-market uses. It outlines key IP assets (patents, trade secrets, know-how, trademarks) and patentability requirements, focusing on novelty, non-obviousness, and Section 112 written description and enablement, with examples from Ariad v. Eli Lilly and Amgen v. Sanofi showing that broad claims require commensurate disclosure. It warns against filing patents based only on targets/antigens or relying on provisional applications without full detail, and discusses timing issues when commercialization may exceed patent term, sometimes favoring trade secrets or licensing protections. It highlights patent opportunities beyond discovery, including methods of treatment, dosing, formulations, delivery, manufacturing, and new uses, noting unpredictability as important in non-obviousness (e.g., OSI v. Apotex).

00:00 Misconceptions and Risks

00:56 Life Science Development Cycle

01:59 IP Assets and Patent Pitfalls

02:37 Patentability and Disclosure

04:16 Written Description Case Law

05:37 Strategy Questions and Timing

08:16 Drug Discovery Patenting

09:01 Provisional Filing Myth

11:20 Preclinical and Clinical Patents

13:28 Wrap Up and Contact

The script explains how patents increase a startup’s chances of securing funding by boosting valuation, attracting investors, improving funding success rates (including 4x higher odds), and enabling larger rounds. It describes a “Shark Tank effect,” citing 70–80% higher investor interest for patented or pending products, and says patents reduce perceived risk, deter idea theft, and signal market validation, technical quality, market potential, and long-term growth commitment. It argues a single strong patent can materially affect valuation, gives examples of barriers to entry (exclusive rights, design-around costs, litigation risk, and patent thickets), and cites ROI metrics such as 6.4x higher funding likelihood, 73% more capital, 93% higher angel-stage valuations, and 51% higher late-stage valuations. The script covers impacts on exits, M&A, partnerships, global scaling, collateralized loans, founder confidence, market positioning, downturn resilience, first-mover advantage, customer perception, talent attraction, and revenue diversification via licensing, royalties, and monetization.

00:00 Patents And Fundg

00:01 Patents and Funding

01:09 Shark Tank Effect

01:09 Shark Tank Effect

02:09 Innovation Commitment

02:09 Innovation Commitment Signals

03:20 One Patent Value

03:20 Single Patent Valuation

04:53 Barriers To Entry

04:53 Barriers to Entry

05:59 Patent Filing ROI

05:59 Patent Filing ROI

07:13 Exit Potential Boost

07:13 Exit Potential Boost

08:15 Bootstrapped Founder Costs

09:18 Punch Above Weight

10:37 Halo Credibility Effect

11:35 Valuation Factors Wrap

14:13 When To File Patents

15:58 Patents In M&A

17:20 Better Partnership Deals

18:04 Scaling Globally With IP

19:30 David Versus Goliath

20:46 Patents As Collateral

21:51 Founder Confidence Boost

22:54 Market Positioning Power

23:49 Downturn Resilience

24:56 First Mover Advantage

27:05 Customer Perception Impact

28:04 Diversify Revenue Streams

29:36 Closing Thoughts